Literature DB >> 17644459

Modeling and spectroscopic studies of bisphosphonate-bone interactions. The Raman, NMR and crystallographic investigations of Ca-HEDP complexes.

Ignacy Cukrowski1, Ljiljana Popović, Werner Barnard, Sylvia O Paul, Petrus H van Rooyen, David C Liles.   

Abstract

Raman spectroscopy was used to study the interactions of bovine bone, hydroxyapatite (HA, as a model of bone) and calcium hydrogen phosphate (CaHPO4) with 1-hydroxyethylidene-1,1-diphosphonic acid, CH(3)C(OH)(PO(3)H(2))2 (HEDP, the oldest known member in the class of bisphosphonates (BPs) that is commonly used as (i) a reference compound for BP activity, a scale of a BP's potency, and (ii) a pain palliative agent). Raman spectra with diminished background fluorescence were obtained using a visible laser line of 514.5 nm. The Raman spectra of the products from the reaction of HEDP with bone, HA and CaHPO4 could be considered virtually identical. This strongly suggests that CaHPO4 forms first from the reaction of bone or HA with HEDP (which also acts as a strong acid), upon which free Ca2+ ions become available for complexation reactions with HEDP. Two complexes were observed using Raman spectroscopy for each of the interactions of HEDP studied here. This shows that HA can be substituted for bone in studies concerned with the interaction of bone with chemical compounds. Also, Raman spectroscopy can be utilized to distinguish between different complexes formed at the solid/solution interface. One of the two complexes has been further characterized using Nuclear Magnetic Resonance (NMR) spectroscopy, as well as single crystal and powder X-ray diffraction (XRD). This complex has been found to be calcium dihydrogen ethane-1-hydroxy-1,1-diphosphonate dihydrate (Ca(CH(3)C(OH)(PO(3)H)(2)).2H2O). Molecular modeling of this calcium complex using Gaussian03 software confirmed the assignments of the Raman vibrational bands.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644459     DOI: 10.1016/j.bone.2007.05.008

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

1.  Adsorption on apatitic calcium phosphates for drug delivery: interaction with bisphosphonate molecules.

Authors:  P Pascaud; F Errassifi; F Brouillet; S Sarda; A Barroug; A Legrouri; C Rey
Journal:  J Mater Sci Mater Med       Date:  2014-05-01       Impact factor: 3.896

2.  Modeling the interaction of seven bisphosphonates with the hydroxyapatite(100) face.

Authors:  Chunyu Chen; Mingzhu Xia; Lei Wu; Chao Zhou; Fengyun Wang
Journal:  J Mol Model       Date:  2012-03-27       Impact factor: 1.810

3.  Potentiating bisphosphonate-based coordination complexes to treat osteolytic metastases.

Authors:  Gabriel Quiñones Vélez; Lesly Carmona-Sarabia; Waldemar A Rodríguez-Silva; Alondra A Rivera Raíces; Lorraine Feliciano Cruz; Tony Hu; Esther Peterson; Vilmalí López-Mejías
Journal:  J Mater Chem B       Date:  2020-03-11       Impact factor: 6.331

4.  Synthesis, solution, and structural characterization of tetrahydrofuranyl-2,2-bisphosphonic acid disodium salt.

Authors:  Elena Maltezou; Marios Stylianou; Sudeshna Roy; Chryssoula Drouza; Anastasios D Keramidas
Journal:  Bioinorg Chem Appl       Date:  2010-05-11       Impact factor: 7.778

5.  Effects of ibandronate-hydroxyapatite on resorptive activity of osteoclasts.

Authors:  Xiaohui Zhang; Jing Hu; Yunfeng Li; Guozhu Yin; En Luo
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

6.  Synthesis and Characterization of PLA-Micro-structured Hydroxyapatite Composite Films.

Authors:  Andreea Madalina Pandele; Andreea Constantinescu; Ionut Cristian Radu; Florin Miculescu; Stefan Ioan Voicu; Lucian Toma Ciocan
Journal:  Materials (Basel)       Date:  2020-01-08       Impact factor: 3.623

7.  Synthesis, characterization and in vitro evaluation of new composite bisphosphonate delivery systems.

Authors:  Joanna Kolmas; Marcin Sobczak; Ewa Olędzka; Grzegorz Nałęcz-Jawecki; Cezary Dębek
Journal:  Int J Mol Sci       Date:  2014-09-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.